Literature DB >> 28350117

Reduced expression of miR‑205‑5p promotes apoptosis and inhibits proliferation and invasion in lung cancer A549 cells by upregulation of ZEB2 and downregulation of erbB3.

Min Jiang1, Ting Zhong2, Wei Zhang3, Zuke Xiao1, Guozhu Hu1, Hong Zhou1, Haibin Kuang2.   

Abstract

Previous studies have demonstrated that microRNA (miR)-205-5p expression is significantly increased in non‑small cell lung cancer tissues and is associated with tumor differentiation grade. The aim of the present study was to explore the effects of miR‑205‑5p on viability, apoptosis and invasion of lung cancer A549 cells. The hsa‑miR‑205‑5p small interfering RNA (siRNA) inhibitor was transfected into A549 cells and expression of miR‑205‑5p was detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). Cell viability, apoptosis and invasion were assayed by Cell Counting kit‑8, Annexin V/propidium iodide double staining and Transwell assay, respectively. Target genes of miR‑205‑5p were predicted using bioinformatics analysis. Expression of mRNA and protein levels of candidate target genes following miR‑205‑5p inhibition were detected using RT‑qPCR and western blot analysis respectively. The results demonstrated that relative survival rates of A549 cells were significantly inhibited in miR‑205‑5p siRNA‑transfected cells at 24 and 48 h compared with control cells. Apoptosis was markedly increased in the miR‑205‑5p siRNA cells compared with control cells. The number of invaded cells following miR‑205‑5p siRNA silencing was significantly decreased compared with control cells. Bioinformatics analysis revealed that erb‑B2 receptor kinase 3 (erbB3), zinc finger E‑box binding homeobox 2 (ZEB2), clathrin heavy chain (CLTC) and mediator complex subunit 1 (MED1) may be potential target genes of miR‑205‑5p. Reduced expression of miR‑205‑5p significantly increased the expression of ZEB2 mRNA and protein, inhibited the expression of erbB3 protein, but had no significant effect on the expression levels of CLTC and MED1. In summary, reduced expression of miR‑205‑5p promoted apoptosis and inhibited proliferation and invasion in lung cancer A549 cells through upregulation of ZEB2 and downregulation of erbB3. The present results suggested that the increased miR‑205‑5p expression observed in non‑small cell lung cancer tissues may contribute to increased proliferation and invasion of lung cancer cells and thus to cancer progression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28350117     DOI: 10.3892/mmr.2017.6398

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  MiR-205-5p Functions as a Tumor Suppressor in Gastric Cancer Cells through Downregulating FAM84B.

Authors:  Xi Chen; Lei Zhang; JingBo Geng; Zhong Chen; XiaoPeng Cui
Journal:  J Oncol       Date:  2022-05-27       Impact factor: 4.501

3.  Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.

Authors:  Suolin Zhang; Yayan Wang
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

4.  MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2.

Authors:  Xiangdong Tong; Peng Su; Haitao Yang; Fusheng Chi; Lin Shen; Xiao Feng; Hongqian Jiang; Xiuchun Zhang; Zhenyuan Wang
Journal:  Exp Ther Med       Date:  2018-10-03       Impact factor: 2.751

5.  Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis.

Authors:  Fengjie Zhu; Zhe Ren
Journal:  Oncol Rep       Date:  2022-05-06       Impact factor: 4.136

6.  Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.

Authors:  Shuang Feng; Xiaomin Cai; Yangyang Li; Xiaoguang Jian; Linxin Zhang; Bin Li
Journal:  J Exp Clin Cancer Res       Date:  2019-02-06

7.  Dieckol inhibits non-small-cell lung cancer cell proliferation and migration by regulating the PI3K/AKT signaling pathway.

Authors:  Chun-Hong Wang; Xiao-Feng Li; Li-Fang Jin; Yan Zhao; Geng-Jun Zhu; Wei-Zhang Shen
Journal:  J Biochem Mol Toxicol       Date:  2019-07-10       Impact factor: 3.642

Review 8.  Genetic and molecular biology of bladder cancer among Iranian patients.

Authors:  Majid Mojarrad; Meysam Moghbeli
Journal:  Mol Genet Genomic Med       Date:  2020-04-06       Impact factor: 2.183

9.  miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.

Authors:  Ulrich Baumgartner; Fabienne Berger; Ali Hashemi Gheinani; Sabrina Sofia Burgener; Katia Monastyrskaya; Erik Vassella
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

10.  miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.

Authors:  Jianjun Huang; Xue Wang; Guobing Wen; Yu Ren
Journal:  Oncol Rep       Date:  2019-09-10       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.